BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

PLoS By Category | Recent PLoS Articles
Non-Clinical Medicine - Science Policy

A Collaboratively-Derived Science-Policy Research Agenda
Published: Friday, March 09, 2012
Author: William J. Sutherland et al.

by William J. Sutherland, Laura Bellingan, Jim R. Bellingham, Jason J. Blackstock, Robert M. Bloomfield, Michael Bravo, Victoria M. Cadman, David D. Cleevely, Andy Clements, Anthony S. Cohen, David R. Cope, Arthur A. Daemmrich, Cristina Devecchi, Laura Diaz Anadon, Simon Denegri, Robert Doubleday, Nicholas R. Dusic, Robert J. Evans, Wai Y. Feng, H. Charles J. Godfray, Paul Harris, Sue E. Hartley, Alison J. Hester, John Holmes, Alan Hughes, Mike Hulme, Colin Irwin, Richard C. Jennings, Gary S. Kass, Peter Littlejohns, Theresa M. Marteau, Glenn McKee, Erik P. Millstone, William J. Nuttall, Susan Owens, Miles M. Parker, Sarah Pearson, Judith Petts, Richard Ploszek, Andrew S. Pullin, Graeme Reid, Keith S. Richards, John G. Robinson, Louise Shaxson, Leonor Sierra, Beck G. Smith, David J. Spiegelhalter, Jack Stilgoe, Andy Stirling, Christopher P. Tyler, David E. Winickoff, Ron L. Zimmern

The need for policy makers to understand science and for scientists to understand policy processes is widely recognised. However, the science-policy relationship is sometimes difficult and occasionally dysfunctional; it is also increasingly visible, because it must deal with contentious issues, or itself becomes a matter of public controversy, or both. We suggest that identifying key unanswered questions on the relationship between science and policy will catalyse and focus research in this field. To identify these questions, a collaborative procedure was employed with 52 participants selected to cover a wide range of experience in both science and policy, including people from government, non-governmental organisations, academia and industry. These participants consulted with colleagues and submitted 239 questions. An initial round of voting was followed by a workshop in which 40 of the most important questions were identified by further discussion and voting. The resulting list includes questions about the effectiveness of science-based decision-making structures; the nature and legitimacy of expertise; the consequences of changes such as increasing transparency; choices among different sources of evidence; the implications of new means of characterising and representing uncertainties; and ways in which policy and political processes affect what counts as authoritative evidence. We expect this exercise to identify important theoretical questions and to help improve the mutual understanding and effectiveness of those working at the interface of science and policy.